Assenagon Asset Management’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Sell |
12,050
-387,872
| -97% | -$7.06M | ﹤0.01% | 1092 |
|
|
2025
Q1 | $7.93M | Sell |
399,922
-191,757
| -32% | -$3.8M | 0.01% | 444 |
|
|
2024
Q4 | $10.1M | Sell |
591,679
-2,882,776
| -83% | -$49.4M | 0.02% | 496 |
|
|
2024
Q3 | $69.5M | Buy |
3,474,455
+92,281
| +3% | +$1.84M | 0.13% | 127 |
|
|
2024
Q2 | $37.8M | Buy |
3,382,174
+35,707
| +1% | +$399K | 0.08% | 163 |
|
|
2024
Q1 | $22.1M | Sell |
3,346,467
-598,758
| -15% | -$3.95M | 0.05% | 239 |
|
|
2023
Q4 | $17.8M | Sell |
3,945,225
-1,088,946
| -22% | -$4.92M | 0.05% | 290 |
|
|
2023
Q3 | $18M | Sell |
5,034,171
-605,799
| -11% | -$2.17M | 0.06% | 247 |
|
|
2023
Q2 | $20.8M | Sell |
5,639,970
-1,025,051
| -15% | -$3.78M | 0.07% | 207 |
|
|
2023
Q1 | $22.1M | Buy |
6,665,021
+4,299,301
| +182% | +$14.2M | 0.08% | 206 |
|
|
2022
Q4 | $9.18M | Buy |
2,365,720
+1,297,973
| +122% | +$5.04M | 0.03% | 371 |
|
|
2022
Q3 | $2.6M | Sell |
1,067,747
-21,360
| -2% | -$51.9K | 0.01% | 617 |
|
|
2022
Q2 | $2.16M | Buy |
1,089,107
+585,707
| +116% | +$1.16M | 0.01% | 783 |
|
|
2022
Q1 | $921K | Buy |
503,400
+371,956
| +283% | +$681K | ﹤0.01% | 1030 |
|
|
2021
Q4 | $185K | Buy |
131,444
+49,899
| +61% | +$70.2K | ﹤0.01% | 1334 |
|
|
2021
Q3 | $92K | Buy |
81,545
+19,169
| +31% | +$21.6K | ﹤0.01% | 1220 |
|
|
2021
Q2 | $100K | Sell |
62,376
-14,811
| -19% | -$23.7K | ﹤0.01% | 1129 |
|
|
2021
Q1 | $136K | Buy |
+77,187
| New | +$136K | ﹤0.01% | 1126 |
|
|
2020
Q3 | – | Sell |
-412,534
| Closed | -$1.21M | – | 1061 |
|
|
2020
Q2 | $1.21M | Buy |
+412,534
| New | +$1.21M | 0.01% | 721 |
|